Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety Network

BACKGROUND: Adults previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) develop short-term immunity and may have increased reactogenicity to coronavirus disease 2019 (COVID-19) vaccines. This prospective, multicenter, active-surveillance cohort study examined the sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Bettinger, Julie A, Irvine, Michael A, Shulha, Hennady P, Valiquette, Louis, Muller, Matthew P, Vanderkooi, Otto G, Kellner, James D, Top, Karina A, Sadarangani, Manish, McGeer, Allison, Isenor, Jennifer E, Marty, Kimberly, Soe, Phyumar, De Serres, Gaston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620384/
https://www.ncbi.nlm.nih.gov/pubmed/36310514
http://dx.doi.org/10.1093/cid/ciac852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620384/
https://www.ncbi.nlm.nih.gov/pubmed/36310514
http://dx.doi.org/10.1093/cid/ciac852

Ejemplares similares